These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36220372)

  • 1. [The position and importance of pharmacovigilance in the Czech Republic and in the world].
    Zatovkaňuková P; Slíva J
    Vnitr Lek; 2022; 68(E-4):10-15. PubMed ID: 36220372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse pharmacovigilance jurisdiction-The right way for global drug safety?
    Zatovkaňuková P; Slíva J
    Eur J Clin Pharmacol; 2024 Mar; 80(3):305-315. PubMed ID: 38135821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction reporting in the Czech Republic 2005-2009.
    Kopečná E; Deščíková V; Vlček J; Mladá J
    Int J Clin Pharm; 2011 Aug; 33(4):683-9. PubMed ID: 21678040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic.
    Dvorackova S; Mala-Ladova K; Zimcikova E; Jirsova E; Steurbaut S; Kubena AA; Kolar J; Maly J
    Int J Clin Pharm; 2021 Aug; 43(4):948-957. PubMed ID: 33245522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
    Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
    Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
    Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
    Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance in China: development and challenges.
    Zhao Y; Wang T; Li G; Sun S
    Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of adverse drug reactions reporting systems: paper based to software based.
    Madhushika MT; Weerarathna TP; Liyanage PLGC; Jayasinghe SS
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1385-1390. PubMed ID: 35788724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
    Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
    Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.
    Worakunphanich W; Youngkong S; Suwankesawong W; Anderson C; Thavorncharoensap M
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholders' knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study.
    Riordan DO; Kinane M; Walsh KA; Shiely F; Eustace J; Bermingham M
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1363-1372. PubMed ID: 32507924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
    Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
    Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of adverse drug reaction reporting in Iran: Correction for underreporting.
    Khalili M; Mesgarpour B; Sharifi H; Golozar A; Haghdoost AA
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1101-1114. PubMed ID: 33772938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Under-reporting of adverse drug reactions, a problem that also involves medicines subject to additional monitoring. Preliminary data from a single-center experience on novel oral anticoagulants].
    Patrignani A; Palmieri G; Ciampani N; Moretti V; Mariani A; Racca L
    G Ital Cardiol (Rome); 2018 Jan; 19(1):54-61. PubMed ID: 29451510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.